The mDCF combination as first-line therapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma
Introduction. There is no consensus regarding the optimal first-line chemotherapy regimen for locally advanced or metastatic esophageal squamous cell carcinoma. The efficacy of standard chemotherapy combinations is limited and therefore has to be improved. Due to the limited accessibility of modern immunotherapy, ch...